What Next: TBD | Tech, power, and the future
Technology
The diabetes medication Ozempic has exploded in popularity, particularly amongst those in Hollywood looking to lose a few extra pounds. But a silver bullet for weight loss leads to a number of questions: Is “buying weight loss” via injection somehow worse than diet and exercise? Are so many people buying and using this drug that people who need it for its intended purpose are missing out? What happened to body positivity?
Guest: Matthew Schneier, feature writer for New York Magazine.
Host: Lizzie O’Leary
If you enjoy this show, please consider signing up for Slate Plus. Slate Plus members get benefits like zero ads on any Slate podcast, bonus episodes of shows like Slow Burn and Dear Prudence—and you’ll be supporting the work we do here on What Next TBD. Sign up now at slate.com/whatnextplus to help support our work.
Learn more about your ad choices. Visit megaphone.fm/adchoices
What Is Elon Musk Thinking?
Decoding the Flood of COVID Data
Should You Get an Antibody Test?
How the Crisis Could Embolden Big Tech
Can We Really Make a Safe Vaccine in 18 Months?
Can the U.S. Really Track the Coronavirus?
The Limits of Coronavirus Predictions
Risking Your Life for $8.71
Where Are All the Tests?
Big Tech Eyes the Pandemic
What If They Close All the Schools?
Did the Internet Doom a Pregnancy?
Did Money Corrupt an A.I. Utopia?
Inside Facebook’s Supreme Court
Coronavirus Tests China's Surveillance State
Iowa’s App-ocalypse
Why Is the U.S. Scared of Huawei?
Which Tech Companies Are Doing the Most Harm?
The Silicon Valley Dream Was Always a Fantasy
How Targeted Ads Started Watching Us All
Create your
podcast in
minutes
It is Free
Slow Burn
Slate Debates
What Next | Daily News and Analysis
Decoder Ring
Amicus With Dahlia Lithwick | Law, justice, and the courts